2-Methylbenzoxazole
(Synonyms: 2-甲基苯并唑) 目录号 : GC60478
2-Methylbenzoxazole是一种内源性代谢产物。
Cas No.:95-21-6
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Quality Control & SDS
- View current batch:
- Purity: >99.50%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
2-Methylbenzoxazole is an endogenous metabolite.
| Cas No. | 95-21-6 | SDF | |
| 别名 | 2-甲基苯并唑 | ||
| Canonical SMILES | CC1=NC2=CC=CC=C2O1 | ||
| 分子式 | C8H7NO | 分子量 | 133.15 |
| 溶解度 | DMSO : 100 mg/mL (751.03 mM; Need ultrasonic) | 储存条件 | Store at -20°C |
| General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。 储备液的保存方式和期限：-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。 为了提高溶解度，请将管子加热至37℃，然后在超声波浴中震荡一段时间。 |
||
| Shipping Condition | 评估样品解决方案：配备蓝冰进行发货。所有其他可用尺寸：配备RT，或根据请求配备蓝冰。 | ||
| 制备储备液 | |||
 |
1 mg | 5 mg | 10 mg |
| 1 mM | 7.5103 mL | 37.5516 mL | 75.1033 mL |
| 5 mM | 1.5021 mL | 7.5103 mL | 15.0207 mL |
| 10 mM | 0.751 mL | 3.7552 mL | 7.5103 mL |
| 第一步：请输入基本实验信息（考虑到实验过程中的损耗，建议多配一只动物的药量） | ||||||||||
| 给药剂量 | mg/kg |  |
动物平均体重 | g | |
每只动物给药体积 | ul | |
动物数量 | 只 |
| 第二步：请输入动物体内配方组成（配方适用于不溶于水的药物；不同批次药物配方比例不同，请联系GLPBIO为您提供正确的澄清溶液配方） | ||||||||||
| % DMSO % % Tween 80 % saline | ||||||||||
| 计算重置 | ||||||||||
计算结果:
工作液浓度： mg/ml；
DMSO母液配制方法： mg 药物溶于 μL DMSO溶液（母液浓度 mg/mL，
体内配方配制方法：取 μL DMSO母液，加入 μL PEG300，混匀澄清后加入μL Tween 80，混匀澄清后加入 μL saline，混匀澄清。
1. 首先保证母液是澄清的；
2.
一定要按照顺序依次将溶剂加入，进行下一步操作之前必须保证上一步操作得到的是澄清的溶液，可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Oxazoles revisited: On the nature of binding of benzoxazole and 2-Methylbenzoxazole with the zinc and palladium halides
Dalton Trans 2011 Feb 21;40(7):1594-600.PMID:21210064DOI:10.1039/c0dt01266a.
A synthetic and structural (X-ray) investigation into the bonding modes of benzoxazole (box) and 2-Methylbenzoxazole (Mebox) ligands with halide precursors of Zn and Pd has been undertaken to clarify earlier discrepancies concerning the nature of the bonding mode(s) of the two azoles. In four structurally characterised examples, all contain the title ligands in a κ(1)N bonding motif. Calculations at the density functional level (DFT) of theory (B3LYP) confirm the ground state stability of this class of coordination for several hypothetical Pd and Zn (gas phase) compounds. The attempt to obtain suitable crystalline material of PdCl(2)(box)(2) (i.e., 5) leads to substantial complex degradation. One minor product of this process has been identified (X-ray) as the diarylformamidinato complex C(26)H(22)N(4)O(4)Pd, presumably formed via a complex combination of the decomposition products of both free box and 5.
Platinum(IV) chloride complexes with heterocyclic ligands
J Inorg Biochem 1987 Feb;29(2):95-100.PMID:3559551DOI:10.1016/0162-0134(87)80016-8.
Platinum(IV) chloride complexes with heterocyclic ligands have been prepared and characterized by infrared and electronic spectra. The compounds are of general formula Pt(L)nCl4, where L = N-ethylimidazole, N-propylimidazole, isoxazole, 3,5-dimethylisoxazole, benzoxazole, 2-Methylbenzoxazole, 2,5-dimethylbenzoxazole, ethylenediamine, n = 2, 4, and also Pt(enEt2)3Cl4 X 2H2O, where enEt2 = N,N-diethylethylenediamine. These complexes are hexacoordinate with cis or trans configuration. The antitumoral activity of some complexes in mice inoculated with leukemia L1210 is reported.
Hydrolytic instability of the important orexin 1 receptor antagonist SB-334867: possible confounding effects on in vivo and in vitro studies
Bioorg Med Chem Lett 2012 Nov 1;22(21):6661-4.PMID:23031594DOI:10.1016/j.bmcl.2012.08.109.
SB-334867 has been an important ligand for the study of the orexin 1 (OX1) receptor due to its high OX1/OX2 selectivity and bioavailability. This ligand however, contains a 2-Methylbenzoxazole ring system which is known to undergo hydrolysis, particularly under acidic or basic conditions. The possibility that SB-334867 would be susceptible to significant hydrolysis was evaluated in various formulations and in the solid state. SB-334867 was found to be unstable under conditions commonly employed to prepare stock solutions for in vitro and in vivo studies. In addition, and most alarmingly, the hydrochloride salt of SB-334867 was found to quantitatively decompose to an OX1-inactive product even in the solid state. These findings combine to suggest that studies using SB-334867 (and any other 2-methylbenzoxazole-containing compound) should be performed with great care to avoid the confounding effects of the rapid hydrolytic decomposition of this susceptible structure.
Diaryl urea analogues of SB-334867 as orexin-1 receptor antagonists
Bioorg Med Chem Lett 2011 May 15;21(10):2980-5.PMID:21478014DOI:10.1016/j.bmcl.2011.03.048.
As a part of our program to develop OX1-CB1 bivalent ligands, we required a better understanding of the basic structure-activity relationships (SARs) of orexin antagonists. A series of SB-334867 analogues were synthesized and evaluated in calcium mobilization assays. SAR results suggest that the 2-Methylbenzoxazole moiety may be replaced with a disubstituted 4-aminophenyl group without loss of activity and an electron-deficient system is generally preferred at the 1,5-naphthyridine moiety for OX1 antagonist activity. In particular, substitution of larger potential linkers such as n-hexyl provided compound 33 with equivalent activity at the OX1 receptor compared to the lead compound SB-334867. These compounds should be of value in the development of ligands targeting the orexin-1 receptor and its potential heterodimers.
Iminocyclohexadienylidenes: Carbenes or Diradicals? The Hetero-Wolff Rearrangement of Benzotriazoles to Cyanocyclopentadienes and 1H-Benzo[b]azirines
J Phys Chem A 2017 Aug 17;121(32):5998-6003.PMID:28718288DOI:10.1021/acs.jpca.7b05325.
The thermal rearrangements of benzotriazole 1 to fulvenimine 4 and 1H-benzazirine 7 are investigated at DFT and CASPT2 levels of theory. Ring opening of benzotriazole 1 to 2-diazo-cyclohexadienimine 2 followed by N2 elimination affords Z- and E-2-iminocyclohexadienylidenes 3, which have triplet ground states (3A″). The open-shell singlet (OSS) (1A″) and closed-shell singlet (CSS) (1A') of 3 lie ∼15 and 40 kcal/mol higher in free energy, respectively. The OSS 3 (1A″) is best described as a 1,3-diradical, whereas the CSS (1A') has the character of a carbene. A hetero-Wolff rearrangement of OSS 3 yields fulvenimine 4, which is a precursor of cyanocyclopentadiene 5, with a calculated activation barrier of 38 kcal/mol at the CASPT2(8,8) level, whereby there is a surface crossing from the OSS to the CSS near the transition state. The barrier for cyclization to 1H-benzo[b]azirine 7 is only ∼13 kcal/mol. Therefore, reaction paths involving the singlet iminocyclohexadienylidene diradicals 3 will necessarily cause equilibration with 1H-benzazirine 7 prior to ring contraction to iminofulvene 4 and cyanocyclopentadiene 5, in agreement with experimental observations based on 13C labeling. The thermolysis of 1-acetylbenzotriazole 7 leads to the analogous N-acetyl-diazocyclohexadienimines 8, N-acetyliminocyclohexadienylidene diradicals 9, and N-acetylfulvenimine 10. The E-N-acetyliminocyclohexadienylidene E9 ring closes to the N-acetyl-1H-benzazirine 11 prior to ring contraction to N-acetylfulvenimine 10, and the Z-N-acetyl-2-diazocyclohexadienimine Z8 ring closes to 2-Methylbenzoxazole 12. 1H-benzazirines are predicted to be spectroscopically observable species.